A major discovery in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in several forms of tumors, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research